Comparison of Hip Reduction Using Magnetic Resonance Imaging or Computed Tomography in Hip Dysplasia

Grand Rapids Medical Education Partners (GRMEP), Helen DeVos Children's Hospital, Grand Rapids, MI, USA.
Journal of pediatric orthopedics (Impact Factor: 1.47). 07/2011; 31(5):525-9. DOI: 10.1097/BPO.0b013e31821f905b
Source: PubMed


The purpose of this paper was to compare the use of computed tomography (CT) versus magnetic resonance imaging (MRI) to evaluate hip reduction in patients with dysplasia of the hip.
A retrospective review of postoperative pelvic CT and MRI in patients <13 months of age with hip dysplasia was performed. Scanner time, anesthesia requirement, cost, and radiation dosage were recorded. Hips were classified as dislocated, subluxated, or reduced. Sensitivity and specificity of CT and MRI were calculated. The outcomes of the subluxated hips were followed.
Thirty-two CT scans and 33 MRI scans in 39 patients were evaluated. CT scanner time was 2.8 minutes, which was significantly less than the 8.9 minutes required for MRI (P=0.0001). Postoperative anesthesia was only required for 1 CT case. Average cost of CT examination was $788 and $1104 for MRI. Average radiation dose with CT examinations was 1 mSv. Of the postoperative nonsubluxated hips (n=30 for CT and n=37 for MRI), CT demonstrated a sensitivity of 100% and a specificity of 96%, whereas MRI exhibited a sensitivity of 100% and a specificity of 100%. Of the postoperative subluxated hips, 66.7% spontaneously reduced, 22.2% remained subluxated, and 11.1% redislocated.
This is the first study to compare these imaging modalities in the evaluation of hip reduction in DDH. This study affirms MRI as an alternative to CT scan. The sensitivity and specificity of both modalities appears excellent. Similar to other studies, a large percentage of subluxated hips in both groups reduce without additional surgical intervention.
Diagnostic level II.

0 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Two-dimensional multiple-echo data image combination (MEDIC) images, as well as conventional T1-weighted and T2-weighted images, were obtained for 38 infants with developmental dysplasia of the hip. We retrospectively reviewed these images to evaluate subjective image quality and femoral head-to-ischium contrast. MEDIC images were considered to be of high quality compared with the conventional T1-weighted (P<0.0001) and T2-weighted images (P<0.05), as well as have a higher contrast than conventional T1-weighted and T2-weighted images (P<0.001, respectively). In conclusion, MEDIC images provide diagnostic improvement in studies on developmental dysplasia of the hip.
    Journal of pediatric orthopaedics. Part B / European Paediatric Orthopaedic Society, Pediatric Orthopaedic Society of North America 09/2013; 23(1). DOI:10.1097/BPB.0000000000000001 · 0.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: As developmental dysplasia of the hip (DDH) is the most common congenital muskuloskeletal anomaly, it seems necessary to give an update on the normal growth, pathoanatomy, diagnostic and therapeutic procedures. Which investigations or procedures have withstood the test of time? What are new therapeutic strategies and considerations? What are the problems? Review of the current literature on DDH supplemented by several years experience in the treatment of this condition by the authors. We have still a long way to achieve the goal of agreement on universal standardization of assessment and treatment methods based on age and staging regarding DDH, as in the Ponseti treatment procedure for clubfoot. Our experiences, as well as the literature suggest the use of Graf's nomenclature for classification of DDH in the first year of life. If dynamic ultrasound (US) shows at least a partial relocation of a decentered hip in the first 6 weeks of life, splinting in human position is advocated. The treatment of a Graf type IV hip joint is very difficult and often need surgery. The established surgical procedures in the literature are still up to date. Radiological follow-up of the affected as well as the unaffected side until the end of the growth phase is mandatory due to the risk of residual dysplasia.
    Der Orthopäde 07/2014; 43(8). DOI:10.1007/s00132-013-2225-7 · 0.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gadolinium-enhanced perfusion MRI (pMRI) after closed reduction/spica casting for developmental dysplasia of the hip (DDH) has been suggested as a potential means to identify and avoid avascular necrosis (AVN). To date, however, no study has evaluated the effectiveness of pMRI in clinical practice or compared it with other approaches (such as postreduction CT scan) to show a difference in the proportion of AVN. (1) Can a pMRI-based protocol be used immediately post closed reduction to minimize the risk that AVN would develop? (2) What are the overall hip-related outcomes after closed reduction/spica casting using this protocol? (3) Do any patient-specific factors at the time of closed reduction predict future AVN? This was a retrospective cohort study at a large tertiary care children's hospital. Between 2009 and 2013 we treated 43 patients with closed reduction/spica casting for DDH, of whom 33 (77%) received a postreduction pMRI. All patients were indicated for pMRI per treating surgeon preference. A convenience sample totaling 25 hips in 22 patients treated with pMRI was then established using the following exclusion criteria: DDH of neuromuscular/syndromic origin, failed initial closed reduction, less than 1 year of clinical and radiographic followup, and subsequent open reduction. Next, the 40 patients treated with closed reduction between 2004 and 2009 were screened until the chronologically most recent 25 hips (after applying the previously mentioned exclusion criteria) were identified in 21 of the first 34 patients (62%) screened. Although termed the CT group, specific postreduction imaging was not a defined inclusion criterion in this group with the majority (21 of 25 [84%]) receiving postreduction CT and the remainder (four of 25 [16%]) receiving only postreduction radiographs. All hips with globally decreased femoral head perfusion on postreduction pMRI were treated with immediate cast removal followed by repeat closed reduction or open reduction, as per surgeon preference, with two of 33 (6%) requiring such further interventions. Salter criteria were then used to determine the proportion of AVN on radiographs at 1-year and final followup. Secondary outcomes including residual dysplasia and the need for further corrective surgery were ascertained through radiographic and retrospective chart review. At 1-year followup there was no difference in the proportion of AVN in the historical CT group as compared with the pMRI group (six of 25 [24%] versus one of 25 [4%]; odds ratio [OR], 7.6; 95% confidence interval [CI], 0.8-363; p = 0.098). However, by final followup there was a statistically higher proportion of AVN in the CT group (seven of 25 [28%] versus one of 25 [4%]; OR, 9.3; 95% CI, 1.0-438; p = 0.049). No patient with normal perfusion on postreduction pMRI went on to develop AVN. In those pMRI patients in whom a successful reduction was initially obtained, two of 25 (8%) went on to require further corrective surgery and one of 25 (4%) had a redislocation event. With the numbers available, no patient-specific factors at the time of closed reduction were predictive of future AVN, including the patient's age/weight, the presence of an ossific nucleus, history of previous bracing treatment, or the abduction angle in spica cast. A pMRI-based protocol immediately after closed reduction/spica casting may decrease the risk of AVN by helping the surgeon to evaluate femoral head vascularity. Although preliminary in nature, this study could serve to guide further investigation into the potential role of pMRI for the treatment of patients who require closed reduction/spica casting for DDH. Level III, therapeutic study.
    Clinical Orthopaedics and Related Research 06/2015; DOI:10.1007/s11999-015-4387-6 · 2.77 Impact Factor